cepharanthine has been researched along with Genetic Predisposition in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuhara, S; Kagawa, H; Matsuzaki, T; Nagahama, M; Nakayama, S; Nomura, S; Ozaki, Y; Yamaoka, M; Yoshimura, C | 1 |
1 other study(ies) available for cepharanthine and Genetic Predisposition
| Article | Year |
|---|---|
Genetic analysis of HLA- and HPA-typing in idiopathic (autoimmune) thrombocytopenic purpura patients treated with cepharanthin.
Topics: Adult; Aged; Alkaloids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Human Platelet; Autoantigens; Autoimmune Diseases; Benzylisoquinolines; Blood Platelets; Combined Modality Therapy; Drug Resistance; Endocytosis; Female; Genetic Predisposition to Disease; Genotype; HLA Antigens; HLA-DQ Antigens; HLA-DQ beta-Chains; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Splenectomy; Treatment Outcome | 1999 |